284 results
8-K
EX-3.1
LXRX
Lexicon Pharmaceuticals Inc
10 May 24
Unregistered Sales of Equity Securities
4:15pm
of this Section 12.01(c) in order to avail itself of the benefits of Section 12.01(c). In case a Public Offering contemplated by this Section 12.01(c
8-K
EX-99.1
LXRX
Lexicon Pharmaceuticals Inc
2 May 24
Lexicon Pharmaceuticals Reports First Quarter 2024
4:07pm
salaries and benefits associated with the addition of the INPEFA sales force and other increased headcount as well as increased travel and marketing
8-K
EX-10.1
vwjl6m8tfp 977
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
EX-99.1
2xnbr3zrb
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
EX-1.1
50y42tvukom4hl6
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
424B5
6809c d8ku4k
29 Dec 23
Prospectus supplement for primary offering
5:27pm
8-K
EX-10.1
tinvl67
29 Dec 23
Entry into a Material Definitive Agreement
4:04pm
8-K
EX-99.1
eq5dixgc1 pv
8 Nov 23
Lexicon Pharmaceuticals Reports Third Quarter 2023
7:22am
8-K
EX-99.1
gstn990
3 Aug 23
Lexicon Pharmaceuticals Reports Second Quarter 2023
4:08pm
8-K
EX-1.1
awzedw2
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
424B5
m092dcf9
1 Jun 23
Prospectus supplement for primary offering
9:08pm